New cancer clinical trial: A Study to Evaluate Patient Preference and Satisfaction of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Participants With HER2-Positive Early Breast Cancer

Published on: September 17, 2018 at 09:30PM

• Tweet
• Share
• Share
• Share
• Share